July 2024 – Page 49 – Goldea Capital

Pacific Financial Corp Earns $2.1 Million, or $0.21 per Diluted Share, for Second Quarter 2024; Net Interest Margin Remains Strong During the Second Quarter at 4.15%; Board of Directors Declares Quarterly Cash Dividend of $0.14 per Share

Written by Customer Service on July 26, 2024. Posted in Public Companies.

ABERDEEN, Wash., July 26, 2024 (GLOBE NEWSWIRE) — Pacific Financial Corporation (OTCQX: PFLC), (“Pacific Financial”) or the (“Company”), the holding company for Bank of the Pacific (the “Bank”), reported net income of $2.1 million, or $0.21 per diluted share for the second quarter of 2024, compared to $2.7 million, or $0.26 per diluted share for the first quarter of 2024, and $3.9 million, or $0.37 per diluted share for the second quarter of 2023. All results are unaudited. Pacific Financials’ second quarter 2024 operating results reflected the following changes from the first quarter of 2024: (1) lower net interest income as deposit costs increased; (2) higher provision for credit losses due primarily to a larger loan portfolio and changes in the economic forecast and assumptions; (3) higher non-interest income due to larger gains...

Great Pacific Gold Completes Phase 2 Sampling Program at Kesar Creek Project in Papua New Guinea

Written by Customer Service on July 26, 2024. Posted in Public Companies.

VANCOUVER, British Columbia, July 26, 2024 (GLOBE NEWSWIRE) — Great Pacific Gold Corp. (“Great Pacific Gold,” “GPAC,” or the “Company”) (TSXV: GPAC) (OTCQX: FSXLF) (Germany: 4TU) is pleased to announce the completion of the Phase 2 soil and chip sampling program at the Kesar Creek Project in Papua New Guinea (see Figure 1). Highlights: 667 soil samples and 8 rock chip samples collected during this phase of work Kesar Creek Project is short distance from multiple epithermal vein and porphyry deposits and targets identified on the adjacent K92 Mining Inc. project (see Figure 2). Previous assays from GPAC sampling include multiple high-grade gold results obtained from veins that align with the orientation and strike of K92 Mining Inc.’s prolific Kora Deposit of 2.3 M Oz at 10.24 g/t Au equivalent Measured and...

OneMedNet Announces $4.6 Million Private Placement

Written by Customer Service on July 26, 2024. Posted in Public Companies.

Institutional investors include affiliates of Off the Chain Capital and Discovery Capital Management MINNEAPOLIS, July 26, 2024 (GLOBE NEWSWIRE) — OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade Real World Data (“RWD”), inclusive of electronic health records, laboratory results and, uniquely, medical imaging, today announced that it has entered into securities purchase agreements with certain institutional investors, including an affiliate of Off the Chain Capital and an affiliate of Discovery Capital Management, in a private placement that resulted in gross proceeds of approximately $4.6 million, before deducting fees and expenses payable by the Company. The private placement closed on July 25, 2024. The price per share of common stock sold in this offering...

Red River Bancshares, Inc. Reports Second Quarter 2024 Financial Results

Written by Customer Service on July 26, 2024. Posted in Public Companies.

ALEXANDRIA, La., July 26, 2024 (GLOBE NEWSWIRE) — Red River Bancshares, Inc. (the “Company”) (Nasdaq: RRBI), the holding company for Red River Bank (the “Bank”), announced today its unaudited financial results for the second quarter of 2024. Net income for the second quarter of 2024 was $8.0 million, or $1.16 per diluted common share (“EPS”), a decrease of $201,000, or 2.5%, compared to $8.2 million, or $1.16 EPS, for the first quarter of 2024, and a decrease of $981,000, or 10.9%, compared to $9.0 million, or $1.25 EPS, for the second quarter of 2023. For the second quarter of 2024, the quarterly return on assets was 1.05%, and the quarterly return on equity was 10.69%. Net income for the six months ended June 30, 2024, was $16.2 million, or $2.31 EPS, a decrease of $2.4 million, or 12.9%, compared to $18.6 million, or $2.58 EPS,...

Webuy Receives Extension to Regain Compliance with Nasdaq’s Minimum Bid Requirements

Written by Customer Service on July 26, 2024. Posted in Public Companies.

Singapore, July 26, 2024 (GLOBE NEWSWIRE) — Webuy Global Ltd. (Nasdaq: WBUY) (“Webuy” or the “Company”), a Southeast Asian community e-commerce retailer, today announced that, following the receipt of a written notice from the Listing Qualifications Department of the Nasdaq Stock Market, LLC (“Nasdaq”) on January 26, 2024 regarding the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Rule”) for continued listing on the Nasdaq Capital Market, it received written notification from Nasdaq, providing an additional 180 calendar days, or until January 21, 2025, to regain compliance with the minimum bid price of U.S. $1.00, as required by Nasdaq Listing Rule. Under Nasdaq Listing Rule 5810(c)(3)(A), if at any time over this period the bid price of Webuy’s shares closes at U.S. $1.00 per share...

ProMIS Neurosciences Announces Up to $122.7 Million Private Placement Financing

Written by Customer Service on July 26, 2024. Posted in Public Companies.

$30.3 million financing upfront with up to an additional $92.4 million tied to exercise of warrants, with certain of the warrants subject to shareholder approval Fundraise supports development of novel antibody PMN310 for Alzheimer’s Disease patients Proceeds expected to support Company beyond 6 month and 12 month data from the PMN310 Phase Ib study in Alzheimer’s patients TORONTO, Ontario and CAMBRIDGE, Massachusetts, July 26, 2024 (GLOBE NEWSWIRE) — ProMIS Neurosciences Inc. (Nasdaq: PMN) (“ProMIS” or the “Company”), a biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), today announced that it has entered into a unit purchase...

Nutraceutical Market to Reach USD 868.38 Billion by 2031

Written by Customer Service on July 26, 2024. Posted in Mergers And Acquisitions.

Westford, USA, July 26, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the Nutraceuticals Market will attain a value of USD 868.38 Billion by 2031, with a CAGR of 9.50 % during the forecast period (2024-2031). There are many factors that are boosting the market growth of nutraceuticals such as preventive healthcare, rising instances of lifestyle-related problems, and consumer focus on healthy diets. The increasing number of consumer spending power in developing economies is also promoting the demand for nutraceuticals products. As people are becoming more conscious about their diets and trying to opt for self-directed cate for treating lifestyles problems like cardiovascular disorders and malnutrition, the demand for dietary supplements and nutraceuticals will continue to rise. Nutraceuticals are also related to many medical health...

Purpose Investments Inc. Announces Final July 2024 Distribution Rate for Purpose High Interest Savings Fund, Purpose US Cash Fund, Purpose Cash Management Fund, and Purpose USD Cash Management Fund

Written by Customer Service on July 26, 2024. Posted in Dividend Reports And Estimates.

TORONTO, July 26, 2024 (GLOBE NEWSWIRE) — Purpose Investments Inc. announced today the final July 2024 distribution rates for Purpose High Interest Savings Fund, Purpose US Cash Fund, Purpose Cash Management Fund, and Purpose USD Cash Management Fund. The following table reflects the final distribution amounts for the month of June. Ex-distribution date is July 29, 2024. Open-End Fund Ticker Symbol Final distribution per unit Record Date Payable Date Distribution Frequency Purpose USD Cash Management Fund – ETF Units MNU.U US $ 0.4831 07/29/2024 08/02/2024 Monthly Purpose Cash Management Fund – ETF Units MNY $ 0.4398 07/29/2024 08/02/2024 Monthly Purpose High Interest Savings Fund – ETF Units PSA $ 0.2108 07/29/2024 08/02/2024 Monthly Purpose US Cash Fund – ETF Units PSU.U US $ 0.4675 07/29/2024 08/02/2024 Monthly About...

TRxADE Health, Inc. Announces Business Combination with Scienture, Inc., in a Transaction Valued at $103 Million

Written by Customer Service on July 26, 2024. Posted in Public Companies.

Scienture, Inc., a private branded and specialty pharmaceutical company, entered into a business combination with TRxADE Health Inc., in an all-stock transaction valued at $103 million. TAMPA, FL and COMMACK, NY, July 26, 2024 (GLOBE NEWSWIRE) — TRxADE HEALTH, INC. (“TRxADE”) (Nasdaq: MEDS) and Scienture, Inc. (“Scienture”) today announced the closing of TRxADE’s business combination with Scienture in an all-stock transaction (the “Business Combination”). TRxADE acquired all of Scienture’s assets in exchange for shares of TRxADE stock, in a combination of common stock and non-voting convertible preferred stock. TRxADE will change its name to “Scienture Holdings, Inc.” subsequent to the future conversion of the non-voting convertible preferred stock and the combined company is intended to continue as a Nasdaq-listed company. The...

JBTC Announces 2nd Quarter 2024 Earnings

Written by Customer Service on July 26, 2024. Posted in Earnings Releases And Operating Results.

JONESTOWN, Pa., July 26, 2024 (GLOBE NEWSWIRE) — JBT Bancorp, Inc. (OTCQX: JBTC) reported quarterly earnings of $2,167,000 or $0.89 per share for the second quarter of 2024. Six-month reported earnings are $3,474,000 or $1.43 per share, up from $3,394,000 or $1.39 per share in the prior year, representing a 2.36% increase in earnings. President & CEO Troy A. Peters stated: “Our earnings increase was primarily driven by our ability to positively manage our net interest income performance, even during a period of rising funding costs.” More information can be found at OTC Markets at www.otcmarkets.com/stock/JBTC/overview. Contact: Andrea Shetterly, EAAashetterly@jbt.bankJonestown Bank & Trust Co. 2 West Market StreetJonestown, PA 17038-0717Phone: 717-865-4246

Month: July 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice